Targeting tumors through the HIF system.
Ratcliffe
P J
PJ
Pugh
C W
CW
Maxwell
P H
PH
D000970:Antineoplastic Agents / Q000494:pharmacology*; D015687:Cell Hypoxia; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors*; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D008957:Models, Genetic; D009687:Nuclear Proteins / Q000037:antagonists & inhibitors*; D020218:Response Elements; D014157:Transcription Factors / Q000037:antagonists & inhibitors*; D015533:Transcriptional Activation / Q000187:drug effects*
D000970:Antineoplastic Agents; D004268:DNA-Binding Proteins; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D009687:Nuclear Proteins; D014157:Transcription Factors